MEAGAN JOHNSON: Open Payments
NPI 1316294275 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,662 in 192 payments from 24 companies in 2025. Trend: 2023 $2,846 · 2024 $3,539 · 2025 $3,662
Food & beverage: $3,471Education: $192
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $685 |
| ABBVIE INC. | 23 | $425 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $324 |
| UCB, Inc. | 21 | $308 |
| Galderma Laboratories, L.P. | 16 | $268 |
| GENZYME CORPORATION | 13 | $246 |
| Janssen Biotech, Inc. | 12 | $225 |
| Arcutis Biotherapeutics, Inc. | 15 | $213 |
| Regeneron Healthcare Solutions, Inc. | 12 | $170 |
| LEO Pharma Inc. | 10 | $142 |
Products named: COSENTYX, DUPIXENT, SKYRIZI, Bimzelx, NEMLUVIO, TREMFYA, Zoryve, ILUMYA.
Industry payments across TX — which companies pay providers there.
